KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Feb 14, 2023 $2.68 $2.75 $2.65 $2.71 812 605
Feb 13, 2023 $2.68 $2.71 $2.62 $2.68 484 694
Feb 10, 2023 $2.74 $2.77 $2.68 $2.69 496 250
Feb 09, 2023 $2.85 $2.89 $2.74 $2.77 497 201
Feb 08, 2023 $2.92 $2.95 $2.82 $2.83 712 827
Feb 07, 2023 $2.92 $2.98 $2.88 $2.95 543 661
Feb 06, 2023 $2.93 $2.95 $2.89 $2.90 634 821
Feb 03, 2023 $2.94 $3.03 $2.85 $2.90 703 766
Feb 02, 2023 $2.91 $3.00 $2.90 $2.95 545 641
Feb 01, 2023 $3.01 $3.03 $2.90 $2.90 702 633
Jan 31, 2023 $2.96 $3.01 $2.95 $3.01 714 798
Jan 30, 2023 $2.92 $2.98 $2.88 $2.95 613 139
Jan 27, 2023 $2.92 $2.97 $2.89 $2.93 659 950
Jan 26, 2023 $2.88 $2.96 $2.86 $2.93 409 583
Jan 25, 2023 $2.79 $2.94 $2.79 $2.87 1 406 304
Jan 24, 2023 $2.77 $2.80 $2.72 $2.78 306 941
Jan 23, 2023 $2.79 $2.79 $2.68 $2.76 379 050
Jan 20, 2023 $2.68 $2.76 $2.65 $2.76 619 003
Jan 19, 2023 $2.60 $2.68 $2.60 $2.64 351 850
Jan 18, 2023 $2.83 $2.84 $2.65 $2.65 579 208
Jan 17, 2023 $2.83 $2.89 $2.76 $2.80 548 800
Jan 13, 2023 $2.87 $2.93 $2.82 $2.85 668 774
Jan 12, 2023 $2.70 $2.87 $2.67 $2.87 1 512 700
Jan 11, 2023 $2.74 $2.82 $2.68 $2.69 730 300
Jan 10, 2023 $2.68 $2.80 $2.65 $2.75 1 011 300
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT